As an independent pharmacy benefit manager (PBM) not beholden to shareholders
with the national scale of servicing members across all 50 states, PBD is in the unique
position to own the majority of our direct contracts with drug manufacturers.
These relationships not only allow us to negotiate the best rates and discounts for
our clients by working directly with drug manufacturers while maintaining constant
dialogue regarding new drug options.
We can eliminate the middleman of rebate aggregators that smaller and less
established PBM’s have to use to negotiate drug costs.
By not owning contracts and requiring aggregators, that additional layer can add an
additional 8-10 percent to drug costs and cost you missed rebate dollars.